Medication info
Empagliflozin 10 mg (Empagliflozin)

Empagliflozin 10 mg (Empagliflozin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›10mg / 1 tablet
Manufacturer / importer
Dong Gu Bio Pharmaceutical Co., Ltd.
Appearance
Light yellow, biconvex, round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202101835 · Approved 2021.02.24 · Insurance code 657308530

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily for monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment No dose adjustment is required for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistent glomerular filtration rate below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those undergoing dialysis, as efficacy is not expected. •Patients with hepatic impairment No dose adjustment is required for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. •Older adults No dose adjustment is required based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of treatment with this medicine is not recommended in adults aged 85 years or older because clinical experience is limited (see Precautions for Use, 4. General Precautions)

Ingredients

Manufacturer
Dong Gu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty in blood glucose control
View approved original text

This drug is used to help control blood glucose levels in adults with type 2 diabetes. It can be administered as monotherapy in conjunction with dietary and exercise therapy. If blood glucose control is not sufficient with monotherapy, it can be used in combination with metformin, or together with metformin and other diabetes medications to enhance blood glucose management. Additionally, it can be administered in conjunction with insulin therapy or with DPP-4 inhibitors. Extra caution is required for patients with cardiovascular disease who have difficulty controlling glucose levels. This drug is used to improve blood glucose control in patients with type 2 diabetes.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily for monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment No dose adjustment is required for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistent glomerular filtration rate below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those undergoing dialysis, as efficacy is not expected. •Patients with hepatic impairment No dose adjustment is required for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. •Older adults No dose adjustment is required based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of treatment with this medicine is not recommended in adults aged 85 years or older because clinical experience is limited (see Precautions for Use, 4. General Precautions)

Precautions

This drug may not be suitable for certain patients. First, it should not be given to patients who are allergic to the active ingredient or any of the components. Also, it is prohibited for use in patients with type 1 diabetes, diabetic ketoacidosis, severely impaired kidney function (glomerular filtration rate below 30 mL/min/1.73m2), end-stage kidney disease, or those undergoing dialysis. This drug contains lactose, so it should not be administered to patients with lactose intolerance, galactose intolerance, or genetic lactase deficiency. For patients with slightly impaired kidney function (glomerular filtration rate below 60 mL/min/1.73m2), it is advisable not to initiate treatment with this drug. If tolerance is good and treatment has started, the dosage should be adjusted or maintained, and treatment should be discontinued if kidney function worsens. In patients with end-stage kidney disease or those undergoing dialysis, the efficacy of this drug is not expected, so it is not used. In patients with heart failure, this drug should be used with caution in mild or moderate cases and is not recommended for severe heart failure patients. When this drug is used in conjunction with insulin or sulfonylureas, the risk of hypoglycemia may increase, so the dosages of these medications may need to be reduced. During the course of treatment with this drug, rare adverse reactions such as ketoacidosis, urinary tract infections, genital infections, fluid volume depletion, and hypoglycemia may occur, so caution is necessary. In particular, ketoacidosis can occur even if blood glucose levels are not high, so if symptoms such as vomiting, abdominal pain, breathing difficulties, or malaise appear, immediate consultation with medical personnel is required. Additionally, this drug can affect the body's fluid status, so elderly patients (especially those over 75 years old) or those with a history of hypotension should be particularly cautious of fluid volume loss and hypotension risks. Regular monitoring of kidney function is recommended during the use of this drug, and assessment should be immediately carried out if kidney function impairment is suspected. Women who are pregnant or planning to become pregnant should avoid this medication, and breastfeeding should be discontinued if this drug is taken during lactation. No specific toxic symptoms have been reported in case of overdose, but appropriate treatment is necessary based on the clinical situation. This drug has not been shown to be safe and effective for children (under 18 years of age), so it should not be used. Finally, caution is necessary regarding the risk of hypoglycemia when driving or operating machinery, especially when taken with insulin or sulfonylureas. Regular health check-ups and attention to unusual symptoms are important during treatment, and this medication should be taken according to a doctor's instructions.

Side effects

  • hypoglycemia
  • ketoacidosis
  • vulvovaginal candidiasis
  • balanitis
  • other genital infections
  • urinary tract infection
  • perineal necrosis
  • pruritus
  • rash
  • urticaria
Show 145 more
  • angioedema
  • decreased fluid volume
  • increased urination
  • difficulty urinating
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • ureteral stones
  • acute kidney injury
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • rhegmatogenous retinal detachment
  • limb trauma
  • road traffic accident
  • splenic injury
  • sternal fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • otalgia
  • positional vertigo
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • abdominal pain
  • dental caries
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • colonic bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • ureteral stones
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • next syndrome
  • hyperlipidemia
  • vitamin D deficiency
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • musculoskeletal pain
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • eye discomfort
  • conjunctival hyperemia
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • residual phlegm
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • palpitations
  • tachycardia
  • atherosclerosis
  • diabetic vascular complications
  • peripheral arterial occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This drug must be stored in a tightly sealed container to protect it from air or moisture. It is recommended to keep the storage temperature between 1 and 30 degrees Celsius at room temperature. Storing it this way helps maintain the drug's efficacy and safety for a long time.

Appearance and packaging

Appearance

Light yellow, biconvex, round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.